BY Scott Merville

MD Anderson and Madison, Wis.-based Exact Sciences Corp. have announced a partnership to co-develop and commercialize several blood-based screening and diagnostic tests for lung cancer.

The goal is to detect lung cancer earlier, when there’s a greater probability of defeating it. Most lung cancer cases are diagnosed after symptoms appear — when the five-year survival rate is low. But when diagnosed earlier, the five-year survival...